Latest News & Events
Santa Fe, NM – January 14, 2012 - Sigma Labs, Inc. (OTCBB: SGLB) announced today that is has been awarded two U.S. Patents. The first award is for a new class of reactive material known as ARMS - Advanced Reactive Materials and Structures - that could be very useful for the future design of more energetic munitions able to deliver equivalent explosive power in a device of roughly half of the weight.
SANTA FE, N.M., Sept. 25, 2012 -- Sigma Labs, Inc. (SGLB) announced today that it was awarded a contract from one of the world's leading suppliers of power generation systems to develop and demonstrate advanced manufacturing repair technology for land-based gas turbines.
SANTA FE, N.M., Sept. 13, 2012 -- Sigma Labs, Inc. (SGLB) announced today that it has signed a non-binding memorandum of understanding ("MOU") with Morris Technologies, Inc. (www.morristech.com) ("Morris Technologies"), a world leader in the field of Additive Manufacturing and 3D printing, which sets forth the parties intent to explore the formation of a joint venture for the purpose of commercializing Sigma Labs' PrintRite3D™ technology for the Additive Manufacturing industry.
Methodology
IPQA® is forward-looking, on-machine, real-time feedback on product and process quality.
Read more...Testimonials
The work that B6 Sigma has done advances the state of the art [for GMAW welding] in several specific ways...
Our News
Sigma Labs, Inc. Receives Contract from Landing Gear Manufacturer Messier-Bugatti-Dowty
SANTA FE, NEW MEXICO –August 16, 2011 - Sigma Labs, Inc. (OTCBB: SGLB.OB) Sigma Labs, Inc. announced today that it received a fourth contract from Messier-Bugatti-Dowty (MBD) to apply Sigma Labs’ In-Process Quality Assurance (IPQA) software to certain critical aspects of MBD’s landing gear manufacturing. This recent contract from MBD’s Canadian division follows three previous contracts from MBD’s UK Division to further introduce our IPQA to specifically address MBD’s next-generation manufacturing needs.
SANTA FE, NEW MEXICO –August 16, 2011 - Sigma Labs, Inc. (OTCBB: SGLB.OB) Sigma Labs, Inc. announced today that it received a fourth contract from Messier-Bugatti-Dowty (MBD) to apply Sigma Labs’ In-Process Quality Assurance (IPQA) software to certain critical aspects of MBD’s landing gear manufacturing. This recent contract from MBD’s Canadian division follows three previous contracts from MBD’s UK Division to further introduce our IPQA to specifically address MBD’s next-generation manufacturing needs.
Mark Cola, President of Sigma Labs, states that "this development effort with MBD seeks to reduce MBD’s manufacturing costs, introduce new quality assurance technology into their manufacturing processes, and help them maintain very high levels of quality and product safety." Vivek Dave, Vice President of Sigma Labs, states that “this contract will enable us to demonstrate important cost-savings aspects of our IPQA software to MBD, and to discuss future interactions and plans as they seek to introduce new and advanced manufacturing technology into their product lines.”
About Sigma Labs, Inc.
Sigma Labs, Inc. comprises leading scientists and engineers from Los Alamos National Laboratory with over 75 years of combined industrial R&D experience. They develop manufacturing and materials technologies and R&D solutions for first-tier integrators like Boeing, Honeywell, Pratt & Whitney, and other commercial firms around the globe. Sigma Labs, Inc. has current contracts with Federal Government and private industry clients to develop technologies from their conception through the design, building, and testing of prototype systems by integrating sensing, software, materials and manufacturing technology risk-reduction solutions. Visit Sigma Labs at www.sigmalabsinc.com which includes the Company’s recently filed quarterly report on Form 10-Q.
Forward-Looking Statements
This news release contains forward-looking statements that reflect Management's current views about future events and financial performance. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks and uncertainties that may cause actual results and events to differ materially from those projected in the forward-looking statements. Risks and uncertainties that could adversely affect us include, without limitation, the loss of major customers, our failure to obtain new contracts, our inability to patent products or processes, our infringement of patents held by others, our inability to finance our business and the other risks and uncertainties that are discussed in our most recent filings with the Securities and Exchange Commission, including our most recent annual report on Form 10-K and our Report on Form 8-K that was filed in connection with the transaction we recently completed with B6 Sigma. The forward-looking statements in this news release are made only as of the date of this news release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE Sigma Labs, Inc.
Mark Cola, President of Sigma Labs, Inc., +1-505-438-2576